Metagenomi to participate in the 44th annual cowen healthcare conference

Emeryville, calif., feb. 29, 2024 (globe newswire) -- metageno­mi, inc. (nas­daq: mgx), a pre­ci­sion genet­ic med­i­cines com­pa­ny com­mit­ted to devel­op­ing cura­tive ther­a­peu­tics for patients using its pro­pri­etary, com­pre­hen­sive metage­nomics-derived gene edit­ing tool­box, today announced that brian c. thomas, ceo & founder, will participate in a panel titled, “emerging genetic therapy approaches,” during the 44th annual cowen healthcare conference on wednesday, march 6, 2024 from 12:50-1:50 pm et in boston.
MGX Ratings Summary
MGX Quant Ranking